Detalhe da pesquisa
1.
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers.
Curr Opin Neurol
; 36(4): 264-275, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37387459
2.
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's Disease.
J Neuropsychiatry Clin Neurosci
; 35(3): 236-243, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710627
3.
Neuropathological correlates of neuropsychiatric symptoms in dementia.
Alzheimers Dement
; 19(4): 1372-1382, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150075
4.
The Psychiatric Phenotype of Anti-NMDA Receptor Encephalitis.
J Neuropsychiatry Clin Neurosci
; 31(1): 70-79, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376787
5.
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.
Neurol Ther
; 12(3): 727-749, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017910
6.
Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease.
J Parkinsons Dis
; 12(5): 1527-1538, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466956
7.
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson's disease.
NPJ Parkinsons Dis
; 8(1): 154, 2022 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371469
8.
Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis.
J Neurol
; 268(8): 2769-2779, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306172
9.
The importance of co-pathologies on neuropsychiatric symptoms in dementia.
Aging (Albany NY)
; 14(23): 9384-9385, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495589